reviewFrontiers in ImmunologyApr 24, 2017GOLD OA

The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases

Indiana University – Purdue University Indianapolis · Indiana University Health

PubMed
Indexed incrossrefdoajpubmed

Abstract

Il1rl1 (also known as ST2) is a member of the IL-1 superfamily, and its only known ligand is IL-33. ST2 exists in two forms as splice variants: a soluble form (sST2), which acts as a decoy receptor, sequesters free IL-33, and does not signal, and a membrane-bound form (ST2), which activates the MyD88/NF-κB signaling pathway to enhance mast cell, Th2, regulatory T cell (Treg), and innate lymphoid cell type 2 functions. sST2 levels are increased in patients with active inflammatory bowel disease, acute cardiac and small bowel transplant allograft rejection, colon and gastric cancers, gut mucosal damage during viral infection, pulmonary disease, heart disease, and graft-versus-host disease. Recently, sST2 has…

Citation impact

613
total citations
FWCI
20.07
Percentile
100%
References
207
Citations per year

Authors

2

Topics & keywords

Keywords
  • Innate lymphoid cell
  • Immunology
  • Interleukin 33
  • Inflammation
  • Immune system
  • Inflammatory bowel disease
  • Signal transduction
  • Innate immune system
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding